Daniel Skovronsky - Feb 1, 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP, CSO & Pres. LRL & LLY Imm
Signature
/s/ Jonathan Groff for Daniel Skovronsky, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 1, 2025
Transactions value $
-$3,247,272
Form type
4
Date filed
2/4/2025, 04:25 PM
Previous filing
Sep 12, 2024
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +8.99K +7.62% $0.00 127K Feb 1, 2025 Direct
transaction LLY Common Stock Tax liability -$3.25M -4K -3.16% $811.08 123K Feb 1, 2025 Direct
holding LLY Common Stock 72.4K Feb 1, 2025 By Trust F1
holding LLY Common Stock 3.26K Feb 1, 2025 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -8.99K -100% $0.00 0 Feb 1, 2025 Common Stock 8.99K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.